
Amylyx Pharmaceuticals: Share Price Bump On OK For ALS Drug May Not Last (NASDAQ:AMLX)
ronstik/iStock via Getty Images Investment Thesis Amylyx Pharmaceuticals (NASDAQ:AMLX) joined the Nasdaq in January this year, raising ~$190m via an Initial Public Offering (“IPO”) at $19 per share, meaning that, just over six months later, […]